A phase II trial evaluating efficacy of neo-/adjuvant EIA CTX, surgery, and radiation therapy in high-risk soft tissue sarcoma.
T. Schmitt
No relevant relationships to disclose
B. Kasper
No relevant relationships to disclose
M. Bischof
No relevant relationships to disclose
B. Lehner
No relevant relationships to disclose
S. Dietrich
No relevant relationships to disclose
A. Dimitrakopoulou-Strauss
No relevant relationships to disclose
L. G. Strauss
No relevant relationships to disclose
G. Mechtersheimer
No relevant relationships to disclose
P. Wuchter
No relevant relationships to disclose
A. D. Ho
No relevant relationships to disclose
G. Egerer
No relevant relationships to disclose